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Abstract
Background To determine the value of the distance doubling
visual acuity test in the diagnosis of nonorganic visual loss in
a comparative observational case series.
Methods Twenty-one consecutive patients with nonorganic
visual acuity loss and 21 subjects with organic visual loss
as controls were included. Best corrected visual acuity was
tested at the normal distance of 5 meters using Landolt Cs.
The patient was then repositioned and best corrected visual
acuity was tested with the previous optotypes at double the
distance via a mirror.
Results Nonorganic visual acuity loss was identified in
21 of 21 patients. Sensitivity and specificity of distance-
doubling visual acuity test in functional visual loss were
found to be 100% (CI; 83%–100%) and 100% (CI; 82%–
100%), respectively.
Conclusion Distance doubling visual acuity test is widely
used to detect nonorganic visual loss. Our results show that
this test has a high specificity and sensitivity to detect
nonorganic visual impairment.
Keywords Nonorganic visual loss . Distance-doubling
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Introduction
Identification of spurious ophthalmologic complaints is
one of the more difficult diagnostic challenges for the
ophthalmologist. One of the most common nonorganic
disturbances in ophthalmology is decreased vision [1, 2],
which has been reported to be found in up to 7% of adults
with visual complaints in an outpatient ophthalmology
clinic setting [3].
Whereas nonorganic blindness may be easily uncovered
by testing pupillary reactions or by evoking optokinetic
nystagmus, nonorganic decreased vision is very challenging
to reveal. Unilateral nonorganic visual loss is best detected
by well-known tests requiring good binocular vision or tests
based on blurring or occluding the better eye without the
patient’s knowledge [4–6]. As in unilateral blindness, the
absence of a relative afferent pupillary defect may indicate
nonorganic decreased vision. However, if the patient
displays symmetrically decreased vision, there are only a
few objective tests to reveal a nonorganic cause, and it may
require considerable time and inventiveness to diagnose this
condition. Yet this form of visual loss requires the greatest
sacrifice of everyday life function on the part of the patient.
These patients often display a discrepancy between the
manner of ambulation and visual acuity (VA), and thus
arouse suspicion of faking their symptoms. For such cases a
test first described by Helmbold in 1896 [7] is widely used.
The test, which is also useful for unilateral nonorganic
visual loss, makes use of the fact that if the distance to the
reading chart is doubled with help of a mirror, the given
stimulus will appear half as large, since the visual angle is
cut in half. Hence the patient will only be able to read
letters twice as large as the original (for example the 20/80
line instead of the 20/40 line) at double the original
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distance. However if the patient is able to read the same line
at double the distance, his actual VA is much better (for
example if he is able to read up to 20/40 at the normal
distance and still recognizes this line at double distance, his
VA is 20/20).
We have named the test “distance-doubling visual acuity
test”, because “mirror test” usually denotes the test for
detection of nonorganic blindness, where eye movements
are triggered when a mirror is moved in front of the
malingering patient. When performing this test, care has to
be taken to avoid learning effects, since patients with
organic visual loss would otherwise be able to read the
same line at double the distance. Although the test has been
in use for over a century, the effectiveness of this test has,
to our knowledge, never been investigated so far. In this
study we assessed the reliability of this test in a clinical
setting.
Material and methods
The research protocol followed the Tenets of the Declaration
of Helsinki. Ethics Committee approval was not required for
this study. All patients had a full neuro-ophthalmologic
work-up.
Forty-seven patients with decreased VA (range 0.05–
0.7) referred to the Neuro-Ophthalmologic Service at the
Kantonsspital St. Gallen, Switzerland were evaluated.
Inclusion criteria: all patients seen by the author DSM in
the years 2005 to 2007 having presumed nonorganic VA
loss were included. In the same time period, patients with
decreased organic VA were included as controls. Patients
with abnormal eye movements, refractive errors of greater
than 5 spherical equivalents or astigmatism exceeding 2.5
diopters, reduced general health conditions or having
difficulties in communicating with the health personnel
were excluded. Five patients with nonorganic loss of
visual acuity had to be excluded because the patients were
lost for follow up.
Twenty-one patients (mean age: 22.8 years, range 7–
52 years) had nonorganic VA reduction (mean VA: 0.31
range: 0.05–0.7). Of these 21 patients, five presented with
monocular visual loss and 16 with symmetrical decreased
vision. Twenty-one patients (mean age: 30 years, range 4–
68 years) had diminished organic VA (mean VA: 0.31,
range: 0.05–0.7). Of these 21 patients, 20 had unilateral VA
loss and one had bilateral VA loss.
The diagnosis of nonorganic visual acuity loss was
assured by a complete, normal neuro-ophthalmic examina-
tion, and by better VA verified by one or several of the
following tests:
By starting with very small optotypes and displaying
disbelief that the patient is not able to read, and proceed
until he reads (for unilateral and symmetric bilateral VA
loss).
By using an optotype chart for detection of nonorganic
visual loss designed by DSM [8] (for unilateral and
symmetric bilateral VA loss).
By using a polarizing test, with each eye seeing different
portions of the eye chart. Polarized numbers at a distance of
5 m were presented (Topcon Auto Chart Projector ACP-6,
Topcon Inc., Paramus, NJ, USA) and patients were asked to
read all visible optotypes.
To exclude visual field defects, kinetic Goldmann
perimetry was performed in all patients older than 10 years
of age. Careful confrontative visual field examination was
accomplished in younger patients.
The following examination procedure, which was always
performed by the same investigator (DSM), was used: VA
was tested on each eye separately by presenting standard-
ized Landolt Cs at a distance of 5 meters (16.4 feet) and
forced choice procedure (Fig. 1a). The patient was
thoroughly instructed about how to read the optotypes.
The subject had to try to identify or otherwise guess the
direction of the C and the line was noted in which
the patient could still read 4 of 4 presented optotypes. The
patient was then asked to move to a pre-defined point at the
level of the Landolt chart, from which point he was able to
see the mirror. It is important that there is an angle between
the chart, the mirror and the patient in order for the patient
not to see himself in the mirror, so as not to arouse the
patient's suspicion. Additionally the patient was then
instructed in the following way about the test: “We will
retest your VAwith a special filter, which often helps to see
more sharply”. The previous clearly legible Landolt C line
was now twice as far away from the patient. Thus the Cs
Fig. 1 VA at 5 m (a). Distance doubling visual acuity at 10 m through
mirror (b)
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were half the size. The patient was then asked to read the
same line via the mirror again using a forced-choice
strategy (Fig. 1b). In addition the patient was asked whether
the filter helped to see the optotypes more clearly. The
whole examination was performed with dimmed lights in
order to avoid the patient seeing a mirror image of the
room, which again might arouse suspicion.
Since reading again the same optotypes at double the
distance corresponds to a doubling of visual acuity, it is
unlikely that learning effects will strongly affect this test.
However, in order to avoid as much as possible a learning
effect, the visual acuity testing procedure has to be carefully
explained at the beginning. Additionally, when testing at
the threshold at single distance, patients should be
persuaded to try to read the optotypes claimed to be
unrecognizable. For visual acuity tests, determination of
repeatability is important, since optotype design, fatigue
and learning effects may influence the results. Measuring of
the repeatability of tests by the same as well as by other
examiners is important when assessing a diagnostic test. We
addressed this by testing inter- and intraobserver variation
in a total of seven patients. Three of these patients had
normal and four had a decrease of VA due to refractive
changes. In the latter, full visual acuity could be achieved
with corrective lenses, making a nonorganic component
highly unlikely. Three different observers were involved to
test for interobserver variation, and intraobserver variation
was tested on three different days.
Results
Table 1 summarizes the visual acuity findings of patients
with nonorganic visual loss. In the first column, visual
acuity obtained with the forced-choice strategy is summa-
rized. The second column displays the VA obtained via the
mirror, which is twice the distance and thus double the VA.
The last column summarizes follow up VA providing an
additional indication for nonorganic visual acuity loss.
In the group with organic visual loss, none of the
patients could read the smallest line when looking at the
Landolt Cs at double the distance via the mirror and 21 out
of 21 of patients (100%) were unable to see this line at
double the distance. In this group, 12% had bilateral visual
loss and 88% had monocular visual loss. Diagnosis in the
group with organic VA loss was as follows: six had
refractive errors, five had proven amblyopia, four had
retinopathies and six had optic nerve neuropathies.
In the group with nonorganic visual field loss, 21 out of
21 patients (100%) were able to read all Landolt Cs at
double the distance. 82% had bilateral visual loss, and 18%
had monocular decreased VA. In pure nonorganic VA loss,
distance-doubling VA was at least twice the claimed VA.
Five of these patients stated that the filter helped to see the
optotypes at double distance more clearly, and 17 stated
that visibility was equal. None of the patients found that
visibility had decreased. All of the patients showed a
significantly better visual acuity after 3 weeks to 12 months.
The neuro-ophthalmic examination remained normal.
Sensitivity was 100% (CI; 82%–100%). Specificity was
100% (CI; 83%–100%). Positive and negative predictive
values of distance-doubling VA in functional visual loss
were found to be 100%.
The test proved to have a very high threshold for false
positive results, since doubling the distance led to inability
of a normal patient to recognize the optotypes. Intra- and
interobserver repeatability of the test as well as reliability at
two levels of VA also showed consistent results. However,
because of the limited number of patients and observers
included, some degree of intra- and interobserver variation
cannot be excluded.
Discussion
Nonorganic visual loss refers to variable loss of vision in
one or both eyes that cannot be explained by an adequate
Table 1 Column 1: Claimed visual acuity (VA), and column 2: VA at
double distance in nonorganic visual loss
1 2 3
Best claimed VA Mirror VA Best VA by other
means/ after follow up
0.2 0.4 0.8
0.2 0.4 0.8
0.08 0.16 1.0
0.3 0.6 1.0
0.6 1.2 1.0
0.4 0.8 1.0
0.2 0.4 0.9
0.3 0.6 0.5
0.2 0.4 0.4
0.1 0.2 0.3
0.5 1.0 0.9
0.4 0.8 1.0
0.4 0.8 0.8
0.4 0.8 0.9
0.4 0.8 1.0
0.3 0.6 0.7
0.1 0.2 1.0
0.2 0.4 1.0
0.6 1.2 1.0
0.1 0.2 0.6
0.5 1.0 0.9
The best VA of either eye is listed. Column 3 shows best VA after
follow-up (range 1–12 months)
Graefes Arch Clin Exp Ophthalmol (2009) 247:855–858 857
organic cause. Thus, disturbances in the ocular media,
refractive errors, macular diseases or dysfunction of the
optic nerve or visual pathway have to be excluded, before
even considering this diagnosis. The broad array of possible
causes for visual loss makes the diagnosis of nonorganic
visual loss very challenging. Possible hints towards this
diagnosis may be obtained by meticulously taking the
patient's history and adhering to any inconsistencies.
Further information can be obtained by observing the
patients’ movements. However, to be able to prove that
the alleged visual loss is imagined, the ophthalmologist
must have an objective and reproducible test.
We describe such a test based on the concept that a
1-minute angle represents normal VA. If the optotype
distance is varied, the visual angle is varied as well,
meaning that a certain angle is half the size at double
distance. In our experience, it is important to instruct the
patient that his VA will be tested with a special filter. This
will motivate the patient, and may help lessen his suspicion.
One should also avoid testing at the absolute threshold
distance, in order for the test to be more reliable. It is very
important to use Landolt Cs or Snellen Es because the
mirror inverts normal letters or numbers and may give the
patient a hint towards the real nature of the test. It is also
important to use dimmed light, because the patient may
recognize surrounding objects through the mirror, which
might arouse suspicion. Helmbold used the test with
numbers. In order to allow reading the numbers normally,
half of the numbers were inverted.
The distance doubling VA test has some limitations and
shortcomings. It is not useful in patients with severe
nonorganic visual loss who claim not to see even the
largest optotypes. It may also produce false positive results
in younger hyperopic patients, because of their ability to
accommodate. In our experience the mirror often represents
a strong accommodation stimulus, and the hyperopic
patient can often read the optotypes at double the distance
via the mirror.
Finally, we would like to point out that our technique must
be used as an extension of the complete neuro-ophthalmologic
examination including, if necessary other examinations such
as electrophysiological tests [9], keratography, and brain
imaging.
In conclusion, using the distance-doubling VA test in
patients referred because of unclear VA proved to be a very
reliable diagnostic tool to discriminate between organic and
nonorganic visual loss.
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